Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dysfibrinogenemia and thrombosis.

J Soria1, C Soria, J P Collet

  • 1GEFFACS, Laboratoire Sainte Marie, Hôtel Dieu, Paris, France.

Nouvelle Revue Francaise D'Hematologie
|January 1, 1991
PubMed
Summary

Dysfibrinogenemia can cause blood clots due to issues with clot breakdown or thrombin binding. Abnormal fibrin clot structure also impairs clot lysis, contributing to thrombosis risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cognitive Functioning in Adults with Phenylketonuria in a Cohort of Spanish Patients.

Behavioural neurology·2023
Same author

Definition of minimal disease activity in psoriasis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

[Prevalence of osteoarticular infections by Enterobacteria producing extended-spectrum -lactamases].

Acta ortopedica mexicana·2020
Same author

Redefining the therapeutic objective in psoriatic patients candidates for biological therapy.

The Journal of dermatological treatment·2017
Same author

Clinical evidence of the role of the cerebellum in the suppression of overt articulatory movements during reading. A study of reading in children and adolescents treated for cerebellar pilocytic astrocytoma.

Cerebellum (London, England)·2014
Same author

Sedation with sevoflurane in postoperative cardiac surgery: influence on troponin T and creatinine values.

Heart, lung and vessels·2014

Area of Science:

  • Hematology
  • Biochemistry
  • Molecular Biology

Background:

  • Dysfibrinogenemia is associated with an increased risk of thrombosis.
  • The precise mechanisms underlying this thrombotic tendency are not fully understood.

Purpose of the Study:

  • To elucidate the mechanisms by which dysfibrinogenemia leads to thrombosis.
  • To investigate the roles of defective clot lysis and thrombin binding in thrombotic events.

Main Methods:

  • Analysis of fibrin clot structure and function in patients with dysfibrinogenemia.
  • Assessment of fibrin clot reactivity towards fibrinolytic enzymes.
  • Evaluation of thrombin binding capacity of abnormal fibrin clots.

Main Results:

  • Thrombosis in dysfibrinogenemia may stem from impaired clot lysis due to poor fibrinolytic enzyme reactivity.
  • Defective thrombin binding capacity of abnormal clots also contributes to thrombotic events.
  • Acquired anomalies in fibrin clot structure can further compromise clot lysis.

Conclusions:

  • Dysfibrinogenemia-associated thrombosis is multifactorial, involving impaired fibrinolysis and altered thrombin interactions.
  • Understanding these mechanisms is crucial for managing thrombotic risks in affected individuals.

Related Experiment Videos